F1SCHEDULE 3Sampling and analysis

Annotations:
Amendments (Textual)

F1PART 3Monitoring for indicative dose and analytical performance characteristics

Monitoring for compliance with the indicative doseF15

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .